Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Head and Neck Cancer
Related studies linked through entity extraction aliases.
Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Cisplatin or Carboplatin Combined With Gemcitabine in Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor
- Status
- COMPLETED
- Phase
- PHASE2
Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE1
Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cytochlor and Tetrahydrouridine as Radiosensitizers and Cisplatin Combined With Radiation Therapy in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (Mouth) or Oropharynx (Throat)
- Status
- COMPLETED
- Phase
- PHASE1
OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases
- Status
- COMPLETED
- Phase
- PHASE1
Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia
- Status
- COMPLETED
- Phase
- PHASE2
Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE3